
<!DOCTYPE html>
<html lang="en">
    <head>
        <title>Case Study: MH_dev_324</title>
    </head>
<style type="text/css">
    /* gridtable */
    table.gridtable {
        font-family: verdana,arial,sans-serif;
        font-size:11px;
        color:#333333;
        border-width: 1px;
        border-color: #666666;
        border-collapse: collapse;
    }
    table.gridtable th {
        border-width: 1px;
        padding: 8px;
        border-style: solid;
        border-color: #666666;
        background-color: #dedede;
    }
    table.gridtable td {
        border-width: 1px;
        padding: 8px;
        border-style: solid;
        border-color: #666666;
        background-color: #ffffff;
    }
    /* /gridtable */
    
    </style>
    
    <body style="font-size: 16px; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol'; padding: 4rem 2rem; direction: ltr">
<figure style="margin-bottom: 6rem">
    <h1>MH_dev_324</h1>
    <div>    <div class="entities" style="line-height: 2.5; direction: ltr">
        <h2>Query:</h2>
            <mark class="entity" style="background: linear-gradient(60deg, #003300, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">interacts_with DB00682?</mark>
    
        
<!--        <mark class="entity" style="background: linear-gradient(60deg, #f08080, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">instance_of a familiar path</mark>-->
    <h2>Candidates: </h2>
            <mark class="entity" style="background: linear-gradient(60deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB00133<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#0</span></mark>

    
            <mark class="entity" style="background: linear-gradient(60deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB00193<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#1</span></mark>

    
            <mark class="entity" style="background: linear-gradient(60deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB00981<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#2</span></mark>

    
            <mark class="entity" style="background: linear-gradient(60deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB03428<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#3</span></mark>

    
            <mark class="entity" style="background: linear-gradient(60deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB04970<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#4</span></mark>

    
            <mark class="entity" style="background: linear-gradient(60deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB06692<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#5</span></mark>

    
            <mark class="entity" style="background: linear-gradient(60deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB08868<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#6</span></mark>

    
            <mark class="entity" style="background: linear-gradient(60deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB09029<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#7</span></mark>

    
            <mark class="entity" style="background: linear-gradient(60deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB09217<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#8</span></mark>

    
<!--        <mark class="entity" style="background: linear-gradient(60deg, #addeee, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">album<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#0</span></mark>-->

        <h2>Answer: </h2>
            <mark class="entity" style="background: linear-gradient(60deg, #860019, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DB00193</mark>

    
<!--        <mark class="entity" style="background: linear-gradient(60deg, #fff68f, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">album -> instance_of a familiar path</mark>-->




<!--        <mark class="entity" style="background: linear-gradient(60deg, #acaeea, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">likely, single<span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">#0</span></mark>-->
    <h2>Graph:</h2>
    <img height="500" src="data:image/jpeg;base64,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" />
    <h2>Model Output:</h2>
    <table class="gridtable">
<tr><th>Score</th><th>DB00133</th><th>DB00193</th><th>DB00981</th><th>DB03428</th><th>DB04970</th><th>DB06692</th><th>DB08868</th><th>DB09029</th><th>DB09217</th></tr><tr><td>Men.</td><td>0.003803834319114685</td><td>0.9564726948738098</td><td>0.003473317250609398</td><td>0.00229260022751987</td><td>0.0046812910586595535</td><td>0.003370450809597969</td><td>0.008496008813381195</td><td>0.011794381774961948</td><td>0.005615433678030968</td></tr><tr><td>Men. Rank</td><td>5</td><td>0</td><td>6</td><td>8</td><td>4</td><td>7</td><td>2</td><td>1</td><td>3</td></tr><tr><td>Can.</td><td>0.00479100551456213</td><td>0.6983874440193176</td><td>0.005687067285180092</td><td>0.0033744960092008114</td><td>0.005404249299317598</td><td>0.007093035615980625</td><td>0.17089921236038208</td><td>0.09219490736722946</td><td>0.012168620713055134</td></tr><tr><td>Can. Rank</td><td>7</td><td>0</td><td>5</td><td>8</td><td>6</td><td>4</td><td>1</td><td>2</td><td>3</td></tr><tr><td>Sum</td><td>0.008594839833676815</td><td>1.6548601388931274</td><td>0.00916038453578949</td><td>0.0056670960038900375</td><td>0.010085539892315865</td><td>0.010463486425578594</td><td>0.17939522862434387</td><td>0.10398928821086884</td><td>0.017784055322408676</td></tr><tr><td>Sum Rank</td><td>7</td><td>0</td><td>6</td><td>8</td><td>5</td><td>4</td><td>1</td><td>2</td><td>3</td></tr>
    </table>
    </div></div><br/><br/><br/><h2 style="margin: 0">0</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Population studies of polymorphisms at loci of neuropsychiatric interest ( tryptophan hydroxylase ( P17752 ) , dopamine transporter protein ( Q01959 ) , D3 dopamine receptor ( P35462 ) , apolipoprotein E ( P02649 ) , mu opioid receptor ( P35372 ) , and ciliary neurotrophic factor ( P26441 ) ) . We determined allele frequencies for polymorphisms at several loci of interest in neuropsychiatry-tryptophan hydroxylase ( P17752 ) , dopamine transporter protein ( Q01959 ) , D3 dopamine receptor ( P35462 ) , apolipoprotein E ( P02649 ) , ciliary neurotrophic factor ( P26441 ) , and the mu opioid receptor ( P35372 ) - in samples of individuals from populations in several different parts of the world . Associations with psychiatric illness have been proposed for specific polymorphisms at P17752 ( suicide-related behaviors and impulsivity ) , P35462 ( schizophrenia and bipolar affective disorder ) , Q01959 ( susceptibility to cocaine-induced paranoia and attention-deficit disorder ) , P26441 ( psychosis ) , and P35372 ( substance dependence ) . P02649 alleles are related to risk of Alzheimer disease . We found significant allele frequency variation among populations at all six loci . These results will provide a global framework of normal variation at these loci that might have functional significance or otherwise be related to susceptibility to various disorders or behavioral phenomena . Knowledge of this variation can be important for study design and data interpretation when individuals from various population groups are research subjects and may eventually help lead to a better understanding of behavioral adaptation .</div>

<h2 style="margin: 0">1</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Inhibition of Q16552 as a pharmacological approach for Q9UKU7 . Several experimental approaches have been utilized , in order to critically examine the roles of Q16552 family members in intestinal inflammation . These approaches have included : ( 1 ) the use of Q16552 and Q96PD4 - deficient mice , ( 2 ) specific antibodies directed against Q16552 , ( 3 ) an Q16552 vaccine , ( 4 ) methods to block the Q16552 receptor and ( 5 ) small-molecule inhibitors of Q16552 . Previous studies found somewhat conflicting results in preclinical models of Inflammatory Bowel Disease ( Q9UKU7 ) , using specific strains of Q16552 - deficient mice . This paper will review the preclinical results using various pharmacological approaches [ specific Q16552 antibodies , an Q16552 receptor fusion protein , IL - 12 / IL - 23 p40 subunit and Q16552 vaccine approaches , as well as a small molecule inhibitor ( Vidofludimus ) ] to inhibit Q16552 in animal models of Q9UKU7 . Recent clinical results in patients with Q9UKU7 will also be discussed for 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB09029
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 ( an Q16552 antibody ) , Brodalumab ( an Q16552 receptor antibody ) and two small-molecule drugs ( Vidofludimus and DB08895 ) , which inhibit Q16552 as part of their overall pharmacological profiles . This review paper will also discuss some pharmacological lessons learned from the preclinical and clinical studies with anti - Q16552 drugs , as related to drug pharmacodynamics , Q16552 receptor subtypes and other pertinent factors . Finally , future pharmacological approaches of interest will be discussed , such as : ( 1 ) Retinoic acid receptor-related orphan nuclear receptor gamma t ( Rorγt ) antagonists , ( 2 ) P10276 ( RARα ) antagonists , ( 3 ) Pim - 1 kinase inhibitors and ( 4 ) Dual small-molecule inhibitors of NF-κB and P40763 , like synthetic triterpenoids .</div>

<h2 style="margin: 0">2</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Consequences of the Y139F Vkorc 1 mutation on resistance to AVKs : in-vivo investigation in a 7th generation of congenic Y139F strain of rats . OBJECTIVES : In humans , warfarin is used as an anticoagulant to reduce the risk of thromboembolic clinical events . 
<mark class="entity" style="background: linear-gradient(90deg, #003300, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00682
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">SUB</span>
</mark>
 derivatives are also used as rodenticides in pest control . The gene encoding the protein targeted by anticoagulants is the Vitamin K -2,3- epoxide reductase subunit 1 ( Q9BQB6 ) . Since its discovery in 2004 , various amino acid and transcription-regulatory altering Q9BQB6 mutations have been identified in patients who required extreme antivitamin K dosages , or wild populations of rodents that were difficult to control with anticoagulant rodenticides . One unresolved question concerns the dependency of the Q9BQB6 on the genetic background in humans and rodents that respond weakly or not at all to anticoagulants . Moreover , an important question requiring further analyses concerns the role of the Vkorc 1 gene in mediating resistance to more recently developed warfarin derivatives ( superwarfarins ) . METHODS : In this study , we bred a quasicongenic rat strain by using a wild-caught anticoagulant resistant rat as a donor to introduce the Y &gt; F amino acid change at position 139 in the Vkorc 1 into the genetic background of an anticoagulant susceptible Spraque-Dawley recipient strain . RESULTS AND CONCLUSION : In this manuscript we report the prothrombin times measured in the P08709 generation after exposure to chlorophacinone , bromadiolone , difenacoum and difethialone . We observed that the mutation Y139F mediates resistance in an otherwise susceptible genetic background when exposed to chlorophacinone and bromadiolone . However , the physiological response to the super-warfarins , difenacoum and difethialone , may be strongly dependent on other genes located outside the congenic interval ( 28.3 cM ) bracketing the Vkorc 1 in our P08709 generation congenic strain .</div>

<h2 style="margin: 0">3</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">P12004 - dependent kinase 5 is associated with risk for Alzheimer ' s disease in a Dutch population-based study . Although the role of the Cdk 5 protein in Alzheimer ' s disease ( AD ) is well recognized , there have been relatively few studies investigating genetic variants in the Q00535 gene in AD . In this study , we assessed the association between five previously described single nucleotide polymorphisms ( SNPs ) in the Q00535 gene and late onset AD by means of logistic regression and haplotype association analyses . Including all prevalent and incident AD cases , we found a significantly increased risk of AD for carriers of the GG genotype of SNP rs2069442 ( OR = 1.79 , 95 % CI 1.16- 2.79 , p = 0.001 ) in those without P02649 * 4 . When limiting the analysis to incident cases without P02649 * 4 , carriers of the GG genotype showed a 1.9- fold increased risk of AD ( 95 % CI 1.16- 3.10 , p = 0.003 ) . Variations in the Q00535 gene can be described in 5 haplotype blocks . In our analysis , the haplotype tagged by the G allele of SNP rs2069442 was significantly associated with AD ( p = 0.05 ) . In conclusion , our study suggests that Q00535 may be associated with AD .</div>

<h2 style="margin: 0">4</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Polymorphisms of the HTR 1a allele are linked to frontal brain electrical asymmetry . Polymorphic variations in genes related to serotonin synthesis , transport , recognition , or degradation may convey subtle changes in serotonin system architecture that may place an individual at risk for psychopathology when faced with life stressors . The relationship between three key serotonin alleles and frontal brain electrical asymmetry , a putative endophenotype of depression , was examined . Risk alleles were hypothesized to predict relatively greater right frontal brain activity regardless of current clinical state . A sample of 313 college-age individuals , spanning a range of depressive severity from no symptomotology to clinically meaningful levels , participated . Resting encephalographic ( EEG ) activity was recorded from 64 scalp sites on four occasions separated by at least 24h ( two 8 - min recording sessions occurring at each occasion ) . Alpha power asymmetry scores between homologous sites were calculated for each session and then averaged to form a trait metric of asymmetry for each pair . PCR based genotyping was conducted for the HTR 1a , HTR 2a , and HTTLPR genes . Variations in the HTR 1a gene were related to trait EEG asymmetry , regardless of any history of depression . Compared to subjects with at least one non-risk allele , subjects with homozygous P08908 risk alleles had significantly greater relative right frontal activity at sites P08709 / P00451 , P12259 / F6 , and F1 / F2 . In conclusion , variation in HTR 1a can influence trait level brain activity , which may ultimately be indicative of risk for psychopathology .</div>

<h2 style="margin: 0">5</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-dependent kinase 2 inhibitors . P12004 - dependent kinases ( CDKs ) are essential in the control of cell cycle progression . Inhibition of CDKs represents a new approach for pharmacological intervention in the treatment of a variety of proliferative diseases , especially cancer . Based on the crystal structure of P24941 in complex with an imidazole indolinone compound 1 ( 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB03428
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 ) , lead optimization through modeling , synthesis , and SAR studies has led to the discovery of a novel series of pyrrolyllactone and pyrrolyllactam indolinones as potent P24941 inhibitors .</div>

<h2 style="margin: 0">6</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin - 23 receptor . A proinflammatory cytokine , interleukin 23 ( IL - 23 ) , plays a role in tumor progression by inducing inflammation in the tumor microenvironment , although there is debate about its role in carcinogenesis . Direct effects of IL - 23 on tumor cells have been reported rarely , and contradictory effects have been observed . Here , we studied such effects of IL - 23 in lung cancer cells in vitro and in vivo and explored the underlying mechanism . We found Q5VWK5 expression in tissues from lung adenocarcinoma and small cell carcinoma but not in lung squamous cell carcinoma tissue . Interestingly , different concentrations of IL - 23 had opposite effects in the same types of cells . We confirmed that the different effects could be explained by differences in binding to the Q5VWK5 ( subunits IL - 23r and IL - 12Rβ1 ) . Low concentrations of IL - 23 promoted the proliferation of Q5VWK5 - positive A549 and P08709 - 1 lung cancer cells by binding to IL - 23r , whereas high concentrations of IL - 23 inhibited proliferation of these cells by binding to both IL - 23r and IL - 12Rβ1 . In contrast , IL - 23 had no effect on Q5VWK5 - negative SK-MES - 1 cells . IL - 23 regulated the growth of human lung cancer cells through its effects on P40763 expression and phosphorylation in a concentration-dependent way ; the Ki - 67 gene was involved in these processes . Our findings demonstrate for the first time that IL - 23 affects the proliferation of Q5VWK5 - positive lung cancer cells and that this effect is dependent on the IL - 23 concentration . This can explain at least part of the inconsistent reports on the role of IL - 23 in the progression of carcinogenesis .</div>

<h2 style="margin: 0">7</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Effects of lesopitron on the central nervous system arising from its interaction with P08908 receptors . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB04970
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 acts as a ligand for central serotonin P08908 receptors . Ki obtained from [ 3H ]8 - OH-DPAT competition studies was 104.8 + / - 10.6 nmol / l . As lesopitron did not affect the binding of [ 3H ] paroxetine , involvement of the serotonin reuptake system in the effects of lesopitron is rejected . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB04970
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 inhibits haloperidol-induced catalepsy that is the consequence of its action on P08908 autoreceptors . The ability of lesopitron to induce 5 - HT syndrome reflects post-synaptic P08908 receptor activation and the reversion of 8 - OHDPAT-induced 5 - HT syndrome by lesopitron suggests a partial agonist effect on this receptor-type . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB04970
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 induced a hypothermic effect due to the enhanced activation of post-synaptic P08908 receptors . The agonist effect of lesopitron on P08908 receptors and its marked hypothermic effect is an added value for this drug and a stimulus to the study of its possible neuroprotective action .</div>

<h2 style="margin: 0">8</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Q9BQB6 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy : transthyretin precursor as a potential biomarker . BACKGROUND : Recognizing specific protein changes in response to drug administration in humans has the potential for the development of personalized medicine . Such changes can be identified by pharmacoproteomics approach based on proteomic technologies . It can also be helpful in matching a particular target-based therapy to a particular marker in a subgroup of patients , in addition to the profile of genetic polymorphism . 
<mark class="entity" style="background: linear-gradient(90deg, #003300, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00682
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">SUB</span>
</mark>
 is a commonly prescribed oral anticoagulant in patients with prosthetic valve disease , venous thromboembolism and stroke . METHODS AND FINDING : We used a combined pharmacogenetics and iTRAQ-coupled LC-MS / MS pharmacoproteomics approach to analyze plasma protein profiles of 53 patients , and identified significantly upregulated level of transthyretin precursor in patients receiving low dose of warfarin but not in those on high dose of warfarin . In addition , real-time RT-PCR , western blotting , human P05231 ELISA assay were done for the results validation . CONCLUSION : This combined pharmacogenomics and pharmacoproteomics approach may be applied for other target-based therapies , in matching a particular marker in a subgroup of patients , in addition to the profile of genetic polymorphism .</div>

<h2 style="margin: 0">9</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">First report of warfarin dose requirements in patients possessing the P11712 * 12 allele . BACKGROUND : 
<mark class="entity" style="background: linear-gradient(90deg, #003300, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00682
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">SUB</span>
</mark>
 is the most frequently prescribed anticoagulant in North America and Europe . It is administered as a racemate , but S-warfarin is principally responsible for its anticoagulant activity . Cytochrome P450 ( CYP ) 2C9 is the enzyme primarily responsible for the metabolism of S-warfarin . Numerous variant alleles of P11712 have been identified . The P11712 * 12 ( rs9332239 ) allele harbors a P489S substitution in P11712 which has been shown to result in a 40 % decline in catalytic activity in vitro . CASES : Four Caucasian patients with a low mean weekly warfarin dose ( MWWD ) were genotyped for P11712 , Q9BQB6 and P02649 variant alleles . None of the four patients carried the common P11712 variant alleles ( * 2 , * 3 , * 5 , * 6 , * 7 , * 8 , * 9 , * 11 , * 13 ) despite a relatively low MWWD ( 23.4 ± 7.94 mg ) compared to 208 patients carrying the CYP 29C9 * 1 genotype ( 32.2 ± 12.65 mg ) . Given that P11712 * 12 confers decreased in vitro activity to the enzyme , we investigated whether these patients carried this allele . All four patients were P11712 * 12 CT heterozygotes . Individual comparisons with patients possessing the same Q9BQB6 and P02649 genotypes also demonstrated lower dose requirements in the patients that possessed P11712 * 12 allele . CONCLUSIONS : There are no reports of the clinical impact of rs9332239 on P11712 substrates . This is the first report of patients with the rare P11712 * 12 genotype and lower warfarin dose requirements .</div>

<h2 style="margin: 0">10</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00133
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 palmitoyltransferase , a key enzyme for de novo synthesis of sphingolipids , is essential for male gametophyte development in Arabidopsis . Sphingolipids are important signaling molecules involved in various cellular activities . De novo sphingolipid synthesis is initiated by a rate-limiting enzyme , serine palmitoyltransferase ( P21549 ) , a heterodimer consisting of LONG-CHAIN BASE 1 ( O15269 ) and O15270 subunits . A mutation in the Arabidopsis thaliana O15269 gene , lcb 1-1 , was found to cause embryo lethality . However , the underpinning molecular and cellular mechanisms remain largely unclear . Here , we report the identification of the fumonisin B ( 1 ) resistant 11-2 ( fbr 11-2 ) mutant , an allele of lcb 1-1 . The fbr 11-2 mutation , most likely an allele stronger than lcb 1-1 , was transmitted only through female gametophytes and caused the formation of abortive microspores . During the second pollen mitosis , fbr 11-2 initiated apoptotic cell death in binucleated microspores characteristic of nuclear DNA fragmentation , followed by cytoplasm shrinkage and organelle degeneration at the trinucleated stage . In addition , a double mutant with T-DNA insertions in two homologous O15270 genes showed a phenotype similar to fbr 11-2 . Consistent with these observations , the FBR 11 / O15269 expression was confined in microspores during microgametogenesis . These results suggest that P21549 - modulated programmed cell death plays an important role in the regulation of male gametophyte development .</div>

<h2 style="margin: 0">11</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese . 
<mark class="entity" style="background: linear-gradient(90deg, #003300, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00682
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">SUB</span>
</mark>
 is a commonly used anticoagulant , whose dose needs to be determined for each individual patient owing to large inter-individual variability in its therapeutic dose . Although several clinical and genetic variables influencing warfarin dose have been identified , uncovering additional factors are critically important for safer use of warfarin . Through a genome-wide association study , we identified single-nucleotide polymorphism ( SNP ) rs2108622 [ cytochrome P450 , family 4 , subfamily F , polypeptide 2 ( P78329 ) ] as a genetic determinant of warfarin responsiveness for Japanese . Stratifying subjects who have been pre-classified according to the genotypes of SNP rs10509680 [ cytochrome P450 , family 2 , subfamily C , polypeptide 9 ( P11712 ) ] and SNP rs9923231 [ vitamin K epoxide reductase complex subunit 1 ( Q9BQB6 ) ] , based on their genotypes of rs2108622 allowed identification of subjects who require higher dose of warfarin . Incorporating genotypes of rs2108622 into a warfarin dosing algorithm that considers age , body surface area , status of amiodarone co-administration and genotypes of SNPs in the P11712 and Q9BQB6 genes improved the model ' s predictability to 43.4 % . In this study , the association of P78329 with warfarin dose of the Japanese has been established for the first time . Besides , a warfarin dosing algorithm that incorporates genotypes of rs2108622 and amiodarone co-administration status was suggested for the Japanese . Our study also implied that common SNPs other than those in the P11712 , Q9BQB6 and P78329 genes that show strong effect on the therapeutic warfarin dose might not exist .</div>

<h2 style="margin: 0">12</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">A new cell culture-based assay quantifies vitamin K 2,3- epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven Q9BQB6 assay . BACKGROUND : 
<mark class="entity" style="background: linear-gradient(90deg, #003300, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00682
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">SUB</span>
</mark>
 directly inhibits the vitamin K 2,3- epoxide reductase complex subunit 1 ( Q9BQB6 ) enzyme to effect anticoagulation . Q9BQB6 function has historically been assessed in vitro using a dithiothreitol ( DTT ) - driven vitamin K 2,3- epoxide reductase ( Q9BQB6 ) assay . 
<mark class="entity" style="background: linear-gradient(90deg, #003300, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00682
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">SUB</span>
</mark>
 inhibits wild-type Q9BQB6 function by the DTT - Q9BQB6 assay . However , Q9BQB6 variants with warfarin resistance-associated missense mutations often show low Q9BQB6 activities and warfarin sensitivity instead of resistance . OBJECTIVES : A cell culture-based , indirect Q9BQB6 assay was developed and characterized that accurately reports warfarin sensitivity or resistance for wild-type and variant Q9BQB6 proteins . METHODS : Human coagulation factor ( F ) IX and Q9BQB6 variants were coexpressed in P29320 293T cells under standardized conditions at various warfarin concentrations . Secreted FIX activity served as surrogate marker to report wild-type and variant Q9BQB6 inhibition by warfarin . RESULTS AND CONCLUSIONS : 
<mark class="entity" style="background: linear-gradient(90deg, #003300, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00682
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">SUB</span>
</mark>
 dose-response curves fit to the secreted FIX activity data for coexpressed hVKORC 1 wild-type , Val 29Leu , Val 45Ala and Leu 128Arg variants . The corresponding calculated IC50 values were 24.7 , 136.4 , 152.0 and 1226.4 nm , respectively . Basal activities in the absence of warfarin for all Q9BQB6 variants were similar to that of wild-type Q9BQB6 . Ranked IC50 values from the cell culture-based assay accurately reflect elevated warfarin dosages for patients with Q9BQB6 missense mutation-associated warfarin resistance .</div>

<h2 style="margin: 0">13</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">In vitro effects and in vivo efficacy of a novel cyclooxygenase - 2 inhibitor in cats with lipopolysaccharide-induced pyrexia . OBJECTIVE : To determine cyclooxygenase ( P36551 ) - 2 selectivity , pharmacokinetic properties , and in vivo efficacy of firocoxib ( Q9NTI2 , 785,713 ) in cats . ANIMALS : 5 healthy male and 14 healthy female domestic shorthair cats . PROCEDURE : Selectivity of firocoxib for inhibiting P35354 was determined by comparing the potency for inhibiting P23219 with that of P35354 in feline blood . Pharmacokinetic properties were determined after i . v . ( 2 mg / kg ) and oral ( 3 mg / kg ) administration in male cats . In vivo efficacy was evaluated in female cats with lipopolysaccharide ( LPS ) - induced pyrexia with administration of firocoxib 1 or 14 hours before LPS challenge . RESULTS : Blood concentrations resulting in 50 % inhibition of P23219 and P35354 activity in vitro were 75 + / - 2 microM and 0.13 + / - 0.03 microM , respectively , and selectivity for inhibiting P35354 relative to P23219 was 58 . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB09217
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 had moderate to high oral bioavailability ( 54 % to 70 % ) , low plasma clearance ( 4.7 to 5.8 mL / min / kg ) , and an elimination half-life of 8.7 to 12.2 hours . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB09217
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 at doses from 0.75 to 3 mg / kg was efficacious in attenuating fever when administered to cats 1 or 14 hours before LPS challenge . CONCLUSIONS AND CLINICAL RELEVANCE : 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB09217
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 is a potent P35354 inhibitor and is the only selective P35354 inhibitor described for use in cats to date . It is effective in attenuating febrile responses in cats when administered 14 hours before LPS challenge , suggesting it would be suitable for once-a-day dosing . Because selective P35354 inhibitors have an improved therapeutic index relative to nonselective nonsteroidal anti-inflammatory drugs in humans , firocoxib has the potential to be a safe , effective anti-inflammatory agent for cats .</div>

<h2 style="margin: 0">14</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Aflatoxin B1 induces Src phosphorylation and stimulates lung cancer cell migration . AflatoxinB 1 ( AFB 1 ) is well known as a potent carcinogen . Epidemiological studies have shown an association between AFB 1 exposure and lung cancer in humans . AFB 1 can induce the mutations of genes such as tumor suppressor p53 through its metabolite AFB 1-8 , 9 - exo-epoxide , which acts as a mutagen to react with DNA . In addition , recent study demonstrates AFB 1 positively regulates type I insulin-like growth factor receptor ( IGF-IR ) signaling in hepatoma cells . The current study aims to determine the effects of AFB 1 on Src kinase and insulin receptor substrate ( P41252 ) in lung cancer cells and the effects of AFB 1 on lung cancer cell migration . To this end , the effects of AFB 1 on P41252 expression , Src , Akt , and P29323 phosphorylation were measured by Western blot analysis . The migration of lung cancer cells was detected by wound-healing assay . AFB 1 downregulates P35568 but paradoxically upregulates Q9Y4H2 through positive regulation of the stability of Q9Y4H2 and the proteasomal degradation of P35568 in lung cancer cell lines A549 and P08709 - 1 . In addition , AFB 1 induces Src , Akt , and P27361 / 2 phosphorylation . Treatment of lung cancer cells with Src inhibitor saracatinib abrogates AFB 1 - induced Q9Y4H2 accumulation . Moreover , AFB 1 stimulates lung cancer cell migration , which can be inhibited by saracatinib . We conclude that AFB 1 may upregulate Q9Y4H2 and stimulate lung cancer cell migration through Src .</div>

<h2 style="margin: 0">15</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">[ A novel function of anti-fibrinolytic factor , P05121 , in the central nervous system : a possible role as the neurotrophic factor ] . P00747 activator inhibitor - 1 ( P05121 ) is a serpin that suppresses fibrinolysis by inhibiting the activity of plasminogen activator ( PA ) . Together with PA , P05121 is expressed in the central nervous system and may play a role in the regulation of PA activity . Our present study has demonstrated that , in cultures of PC - 12 neurons , depletion of P05121 from the culture medium induces disappearance of the cell ' s neurites and the cell death . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB06692
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 and antipain , the inhibitors of PA , were not counterparts of P05121 in the protection of neurite disappearance . We also found that P05121 had the abilities to promote release of the survival factors of neurons , P05231 and P15692 and activation of a survival serine / threonine kinase Akt . These results suggest that P05121 has physiological functions other than its role as PA inhibitor for the survival of neurons .</div>

<h2 style="margin: 0">16</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">P21453 as a useful target for treatment of multiple sclerosis . DB03203 1 - phosphate ( Q14703 ) , a lysophospholipid mediator , is generated from sphingosine by sphingosine kinases and binds five known cell surface receptors . P21453 ( P21453 ) plays an essential role in lymphocyte egress from secondary lymphoid organs ( Q12791 ) , as evinced by the inability of lymphocytes to exit from the Q12791 in mice lacking lymphocytic P21453 . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB08868
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 hydrochloride ( FTY 720 ) is a first-in-class , orally active , Q14703 receptor modulator with a structure closely related to sphingosine . FTY 720 was first synthesized by chemical modification of a natural product , myriocin . FTY 720 is effectively converted to an active metabolite , FTY 720 phosphate ( FTY 720 - P ) by sphingosine kinases . FTY 720 - P shows high affinity to 4 of the Q14703 receptors ( P21453 , Q99500 , O95977 , and Q9H228 ) . In particular , FTY 720 - P strongly induces internalization and degradation of P21453 , inhibits Q14703 responsiveness of lymphocytes in the Q12791 , and acts as a functional antagonist at lymphocytic P21453 . Consequently , FTY 720 inhibits P21453 - dependent lymphocyte egress from the Q12791 to decrease circulation of lymphocytes including autoreactive Th17 cells and is highly effective in experimental autoimmune encephalomyelitis ( EAE ) , an animal model of multiple sclerosis ( MS ) . Because FTY 720 shows a superior efficacy in relapsing remitting MS patients compared to intramuscular interferon-β - 1a ( Avonex ® ) , P21453 is presumed to be a useful target for the therapy of MS .</div>

<h2 style="margin: 0">17</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Evaluation of commercial antibodies against human sphingosine - 1 - phosphate receptor 1 . DB03203 - 1 - phosphate receptor 1 ( P21453 ) , also called endothelial differentiation gene 1 , plays an important role in migration , proliferation , and survival of several types of cells including endothelial cells and lymphocytes and is involved in multiple sclerosis . Two commercial rabbit anti - P21453 antibodies ( polyclonal and monoclonal ) were tested on CHO cells expressing P21453 receptors fused to the green fluorescent protein at the C-terminal end and on Pichia pastoris and P29320 cells expressing cmyc-tagged P21453 . Polyclonal antibodies did not give any signal by Western blot , immunofluorescence , and flow cytofluorometry . Monoclonal antibodies were able to reveal an unspecific band by Western blot performed on various cell types . Consequently , in our hands and using our protocols , we show that these antibodies did not specifically detect P21453 receptors .</div>

<h2 style="margin: 0">18</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1 . Hereditary sensory and autonomic neuropathy type 1 ( HSAN 1 ) causes sensory loss that predominantly affects the lower limbs , often preceded by hyperpathia and spontaneous shooting or lancinating pain . It is caused by several missense mutations in the genes encoding 2 of the 3 subunits of the enzyme serine palmitoyltransferase ( P21549 ) . The mutant forms of the enzyme show a shift from their canonical substrate L-serine to the alternative substrate L-alanine . This shift leads to increased formation of neurotoxic deoxysphingolipids ( dSLs ) . Our initial analysis showed that in P29320 cells transfected with O15269 mutants , dSL generation was modulated in vitro in the presence of various amino acids . We therefore examined whether in vivo specific amino acid substrate supplementation influenced dSL levels and disease severity in HSAN 1 . In mice bearing a transgene expressing the C133W O15269 mutant linked to HSAN 1 , a 10 % L-serine – enriched diet reduced dSL levels . L-serine supplementation also improved measures of motor and sensory performance as well as measures of male fertility . In contrast , a 10 % L-alanine – enriched diet increased dSL levels and led to severe peripheral neuropathy . In a pilot study with 14 HSAN 1 patients , L-serine supplementation similarly reduced dSL levels . These observations support the hypothesis that an altered substrate selectivity of the mutant P21549 is key to the pathophysiology of HSAN 1 and raise the prospect of l-serine supplementation as a first treatment option for this disorder .</div>

<h2 style="margin: 0">19</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">Cytochromes P450 are differently expressed in normal and varicose human saphenous veins : linkage with varicosis . The expression of cytochrome P450 ( CYP ) enzymes and cyclo-oxygenases ( P36551 ) was investigated in human saphenous veins by reverse transcription-polymerase chain reaction analysis . Non-varicose veins were obtained from patients undergoing aortocoronary bypass grafting , whereas varicose veins were obtained from patients undergoing stripping removal of varicose saphenous veins . In non-varicose veins , Q16678 , CYP 2C , P05181 and Q02928 were detected , whereas P51589 , P20815 , P23219 and P35354 were detected almost exclusively in varicose veins . P78329 was not detectable . Except for Q02928 , the levels of individual CYP mRNA were higher in varicose veins than in control veins . Smooth muscle cell volume , determined by a colour image-analysis system , was increased approximately 1.5- fold in varicose veins . Because CYPs and COXs produce various vasoactive compounds , increased expression of these enzymes could be involved in the impairment of vascular tone and may contribute to varicose pathology . Then , CYP or P36551 modulators may be potentially active in the treatment of chronic venous insufficiency .</div>

<h2 style="margin: 0">20</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">P35372 - dependent and independent components in effects of tramadol . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00193
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 is thought to induce analgesia via both opioid and non-opioid pathways , although the precise mechanisms remain to be elucidated . In this study , we investigated the roles of the mu-opioid receptor ( MOP ) in analgesic and rewarding effects of tramadol by using MOP knockout ( KO ) mice . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #CC9966); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00193
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MENMAX</span>
</mark>

<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00193
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 - induced antinociception , assessed by hot-plate and tail-flick tests , was significantly reduced in heterozygous and homozygous MOP-KO mice when compared with that in wild-type mice . Interestingly , however , tramadol retained its ability to induce significant antinociception in homozygous MOP-KO mice . The tramadol-induced antinociception remaining in homozygous MOP-KO mice was not significantly affected by methysergide , a serotonin receptor antagonist , but was partially blocked by yohimbine , an adrenaline alpha 2 receptor antagonist , and both naloxone , a non-selective opioid receptor antagonist , and yohimbine . In addition , antinociceptive effects of an active tramadol metabolite M1 were abolished or remarkably reduced in MOP-KO mice . On the other hand , neither wild-type nor homozygous MOP-KO mice showed significant place preference for tramadol in a conditioned place preference test , although there were slight tendencies toward preference in wild-type mice and avoidance in homozygous MOP-KO mice . These results strongly support the idea suggested in the previous pharmacological studies that MOP and the adrenaline alpha 2 receptor mediate most of the analgesic properties of tramadol .</div>

<h2 style="margin: 0">21</h2>

<div class="entities" style="line-height: 2.5; direction: ltr">An acetylcholinesterase inhibitor , eserine , induces long-term depression at P07451 - P00915 synapses in the hippocampus of adult rats . Studies in humans and rodents support a role for muscarinic ACh receptor ( mAChR ) and nicotinic AChR in learning and memory , and both regulate hippocampal synaptic plasticity using complex and often times opposing mechanisms . P22303 ( P22303 ) inhibitors are commonly prescribed to enhance cholinergic signaling in Alzheimer ' s disease in hopes of rescuing cognitive function , caused , in part , by degeneration of cholinergic innervation to the hippocampus and cortex . Unfortunately , therapeutic efficacy is moderate and inconsistent , perhaps due to unanticipated mechanisms . M1 mAChRs bidirectionally control synaptic strength at P07451 - P00915 synapses ; weak pharmacological activation using carbachol ( CCh ) facilitates potentiation , whereas strong agonism induces muscarinic long-term depression ( mLTD ) via an P29323 - dependent mechanism . Here , we tested the prediction that accumulation of extracellular ACh via inhibition of P22303 is sufficient to induce LTD at P07451 - P00915 synapses in hippocampal slices from adult rats . Although P22303 inhibition with eserine induces LTD , it unexpectedly does not share properties with mLTD induced by CCh , as reported previously . 
<mark class="entity" style="background: linear-gradient(90deg, #CC9966, #ffffff); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DB00981
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MEN</span>
</mark>
 - LTD was prevented by the M3 mAChR-preferring antagonist 1,1- dimethyl - 4 - diphenylacetoxypiperidinium iodide ( 4 - DAMP ) , and pharmacological inhibition of MEK was completely ineffective . Additionally , pharmacological inhibition of p38 MAPK prevents mLTD but has no effect on eserine-LTD . Finally , long-term expression of eserine-LTD is partially dependent on a decrease in presynaptic release probability , likely caused by tonic activation of mAChRs by the sustained increase in extracellular ACh . Thus these findings extend current literature by showing that pharmacological P22303 inhibition causes a prolonged decrease in presynaptic glutamate release at P07451 - P00915 synapses , in addition to inducing a likely postsynaptic form of LTD .</div>

</figure>
</body>
</html>

